Evidence map›Paper›PMID 27211820›Full record

ArticleScientific reports2016

Genetic manipulation of iron biomineralization enhances MR relaxivity in a ferritin-M6A chimeric complex.

Marina Radoul, Limor Lewin, Batya Cohen, Roni Oren, Stanislav Popov, Geula Davidov, Moriel H Vandsburger, Alon Harmelin, Ronit Bitton, Jean-Marc Greneche and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. N6-methyladenosine and Neurological Diseases.Molecular neurobiology · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Probing the brain with molecular fMRI.Current opinion in neurobiology · 2018
    Review
  14. Biomolecular MRI reporters: Evolution of new mechanisms.Progress in nuclear magnetic resonance spectroscopy · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Marina RadoulDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100 Israel.
Limor LewinDepartment of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, POB 653, Beer-Sheva 84105, Israel.
Batya CohenDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100 Israel.
Roni OrenDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100 Israel.
Stanislav PopovDepartment of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, POB 653, Beer-Sheva 84105, Israel.
Geula DavidovDepartment of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, POB 653, Beer-Sheva 84105, Israel.
Moriel H VandsburgerDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100 Israel.
Alon HarmelinDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot 76100 Israel.
Ronit BittonDepartment of Chemical Engineering and Ilse Katz Institute for Nanoscale Science and Technology Ben-Gurion University of the Negev, 84105 Beer-Sheva, Israel.
Jean-Marc GrenecheInstitut des Molécules et Matériaux du Mans (IMMM), UMR CNRS 6283 Université du Maine, Avenue Olivier Messiaen, 72085 Le Mans Cedex France.
Michal NeemanDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100 Israel.
Raz ZarivachDepartment of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, POB 653, Beer-Sheva 84105, Israel.
Weizmann Institute of Science · ILIsrael Institute for Biological Research · ILInstitut des Molécules et Matériaux du Mans · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferritin has gained significant attention as a potential reporter gene for in vivo imaging by magnetic resonance imaging (MRI). However, due to the ferritin ferrihydrite core, the relaxivity and sensitivity for detection of native ferritin is relatively low. We report here on a novel chimeric magneto-ferritin reporter gene - ferritin-M6A - in which the magnetite binding peptide from the magnetotactic bacteria magnetosome-associated Mms6 protein was fused to the C-terminal of murine h-ferritin. Biophysical experiments showed that purified ferritin-M6A assembled into a stable protein cage with the M6A protruding into the cage core, enabling magnetite biomineralisation. Ferritin-M6A-expressing C6-glioma cells showed enhanced (per iron) r2 relaxivity. MRI in vivo studies of ferritin-M6A-expressing tumour xenografts showed enhanced R2 relaxation rate in the central hypoxic region of the tumours. Such enhanced relaxivity would increase the sensitivity of ferritin as a reporter gene for non-invasive in vivo MRI-monitoring of cell delivery and differentiation in cellular or gene-based therapies.

Indexed as

AnimalsApoferritinsBacterial ProteinsBrain NeoplasmsCell Line, TumorFerric CompoundsFerrosoferric OxideGenes, ReporterGenetic EngineeringMagnetic Resonance ImagingMiceModels, MolecularNeoplasm TransplantationRatsRecombinant Fusion ProteinsApoferritinsBacterial ProteinsFerric Compoundsferric oxideFerrosoferric OxideRecombinant Fusion Proteins

Identifiers

PMID27211820
PMCPMC4876375
OpenAlexW2407094878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.